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ABSTRACT 
Gel aspiration-ejection (GAE) has recently been introduced as an effective technique for 
the rapid production of injectable dense collagen (IDC) gel scaffolds with tunable collagen 
fibrillar densities (CFDs) and microstructures. Herein, a GAE system was applied for the 
advanced production and delivery of IDC and IDC-Bioglass® (IDC-BG) hybrid gel scaffolds for 
potential bone tissue engineering applications. The efficacy of GAE in generating mineralizable 
IDC-BG gels (from an initial 75-25 collagen-BG ratio) produced through needle gauge numbers 
8G (3.4 mm diameter and 6 wt% CFD) and 14G (1.6 mm diameter and 14 wt% CFD) was 
investigated. Second harmonic generation (SHG) imaging of as-made gels revealed an increase 
in collagen fibril alignment with needle gauge number.  In vitro mineralization of IDC-BG gels 
was confirmed where carbonated hydroxyapatite was detected as early as day 1 in simulated 
body fluid, which progressively increased up to day 14. In vivo mineralization of, and host 
response to, acellular IDC and IDC-BG gel scaffolds were further investigated following 
subcutaneous injection in adult rats. Mineralization, neovascularization and cell infiltration into 
the scaffolds was enhanced by the addition of BG and at day 21 post injection, there was 
evidence of remodelling of granulation tissue into woven bone-like tissue in IDC-BG. SHG 
imaging of explanted scaffolds indicated collagen fibril remodelling through cell infiltration and 
mineralization over time. In sum, the results suggest that IDC-BG hybrid gels have 
osteoinductive properties and potentially offer a novel therapeutic approach for procedures 
requiring the injectable delivery of a malleable and dynamic bone graft that mineralizes under 
physiological conditions. 
Keywords: dense collagen; hydrogel; hydroxyapatite; osteoinduction, subcutaneous injection; 
ectopic bone formation 
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Introduction 
Current bone repair techniques include the implantation of autologous, allogeneic, or 
prosthetic materials [1]. Although these approaches achieve a degree of functional restoration, 
they possess inherent limitations, such as donor-site morbidity and unpredictable graft resorption 
[1, 2]. Therefore, there is an ever-increasing demand for new biomaterials for the replacement, 
construction or augmentation of bone. In particular, there is a need for injectable, and bioactive 
materials for bone regeneration [1, 3, 4].  
Hydrogels of type I collagen, the most abundant protein in the body and the main organic 
component of bone, have excellent biocompatibility, can form physiologically relevant scaffolds 
and can be injectable. Collagen is widely applied for the engineering of scaffolds for potential 
clinical applications in regenerative medicine including bone replacement and void filling [1, 5]. 
However, highly-hydrated collagen (HHC) hydrogels are rapidly absorbed in vivo, suffer from 
weak mechanical properties, and more importantly are difficult to mineralize under physiological 
conditions [6], thus limiting their usage for bone tissue engineering. On the other hand, collagen 
gel hybridization with organic factors that favour osteoid formation, such as recombinant bone 
morphogenetic proteins have shown mixed results due to suboptimal local growth factor 
concentrations as well as non-specific cellular activity [7]. In contrast, the incorporation of 
inorganic bioactive glasses has been shown to increase bioactivity and mineralization, control 
scaffold degradation rate, and improve the structural integrity of collagen scaffolds [8, 9]. The 
commercially available bioactive glass 45S5 Bioglass® (BG) of the composition (45)SiO2–
(24.5)Na2O–(24.5)CaO–(6)P2O5 (wt%), has been proven to favour local deposition of carbonated 
hydroxyapatite (CHA) in physiological environments [10]. In a recent review, Hench and 
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Greenspan [10] described the mechanism for the collagen-BG interface created by the CHA 
crystals which increases the fracture toughness of the BG-bone interface. 
Various techniques have been used to fabricate collagen-BG composite scaffolds [11], 
such as freeze-drying [12], surface coating through immersion in a suspension of BG [8, 13], and 
the pipetting of collagen-BG solutions onto collagen sponges [14]. While highly porous three-
dimensional scaffolds are produced through these approaches, the necessities of extended 
processing steps limit their ease of delivery. It has also been shown that native osteoid 
mimicking scaffolds can be rapidly generated by plastically compressing prefabricated HHC-BG 
hybrid gels [9, 15, 16]. Through a brief application of a unidirectional compressive stress [17], 
the collagen fibrillar density (CFD, i.e., dry to wet weight ratio) of HHC-BG hybrid gels is 
significantly increased for improved mechanical, biological and microstructural properties [9, 
15]. However, the resultant scaffolds are planar-shaped and require rolling and material trimming 
to yield implantable, cylindrical-shaped constructs that match the dimensions of osseous defects 
which are often irregular in volume.  Furthermore, there is still a need for introducing a higher 
degree of control on the microstructure and more feasibility for clinical injections of scaffolds 
[11]. 
Recently, a gel aspiration-ejection (GAE) technique was developed for the production of 
injectable dense collagen (IDC) gel scaffolds with tunable CFDs and microstructures [18]. 
Through the application of pressure differentials, GAE initially draws prefabricated HHC 
hydrogels into a blunt needle, simultaneously imparting compaction and anisotropy on the gels, 
which are then ejected to generate IDC gels. These rapid and tunable microstructural changes of 
more stable collagen hydrogels may enable broad clinical applications. To this end, the efficacy 
of the GAE technique, which allows for the hybridization of collagen gels for increased 
 5 
functionalization [18], was investigated in generating IDC gel scaffolds incorporated with BG 
microparticles (IDC-BG) for controllable mineralization and potential applications in bone tissue 
engineering. Furthermore, in order to ultimately ease IDC-BG translation towards clinical 
applications, a GAE system was developed for the advanced production and delivery of IDC 
gels. Therefore, the aim of this study was to assess the potential clinical feasibility of the GAE 
system in generating IDC-BG hybrid gel scaffolds of distinct microstructural properties (i.e., 
collagen fibrillar density and extent of alignment) imparted by two different needle gauge sizes. 
The potential clinical outlook for in situ bone defect injections was determined by analyzing the 
physiological mineralization of the gel scaffolds both in vitro and in vivo by immersion in 
simulated body fluid (SBF) and subcutaneous injection in adult rats, respectively. Along with 
assessing host responses, the latter model was chosen to investigate any possible osteoinductive 
properties of IDC-BG hybrids as a prelude to their implantation in a bone defect model. 
Materials and Methods  
Fabrication of IDC-BG gel scaffolds 
Bioactive glass particles (of a similar formulation to Bioglass® 45S5)  with an average 
diameter of 7.0±4.1 µm were dispersed in 10x-concentrated Dulbecco’s Modified Eagle Medium 
(10x DMEM; Sigma Aldrich, Canada) by sonication (~ 5 min) to produce a BG-DMEM solution 
with pre-defined mass ratios, as schematically depicted in Fig. 1A. Bovine dermis derived type-I 
collagen (6 mg/mL, in acidic solution, Collagen Solutions Ltd, UK) was added to the BG-
DMEM solution at a 4:1 ratio to yield a final collagen concentration of 4.8 mg/mL. Collagen-
DMEM solution served as the control solution (i.e., 0% BG). Following neutralization using 
NaOH, a standardized IDC processing method was established using the 48-well culture plate 
(Costar Corp, USA) to ensure the reproducible production of sterile IDC gels via GAE. Aliquots 
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of 1.5 mL of the solution were initially fibrilized in individual wells by incubating at 37 °C for 
30 min to produce precursor HHC (with and without BG) gels.  IDC and IDC-BG gels were 
produced through the GAE system, which consisted of a pressure delivery device commonly 
used in angioplasty and kyphoplasty procedures (B. Braun Medical Inc., Germany) to apply 
pressure differentials; a syringe to introduce an incompressible fluid necessary for the ejection 
process (Fisher); two Luer lock valves that are attached in series to the Luer lock tip of the 
pressure delivery device to control flow direction (Fisher); and interchangeable blunt stainless-
steel needles (Hamilton Co., USA) used to dictate aspiration extent (Fig. 1B-C).  
To assess the consistency of the fabrication process, IDC-BG gel scaffolds were generated 
using four standard gauge numbers from 8-14G and two BG concentrations (Table 1; N = 3 in 
each group). Gel CFD values were determined by calculating the ratio of dry to wet weight 
(assuming that no collagen was lost during GAE). Scaffolds were weighed before and after 
freeze-drying (VirTis Benchtop, USA) at -105 °C and 100 mtorr applied for 24 h. Although 
higher needle gauges (i.e., smaller diameters) yielded higher CFD values, the scaffolds exhibited 
less retention of BG microparticles. BG particle loss was noteworthy at 50-50 collagen-BG ratio, 
which may be due to a greater pressure gradient imposed by the narrower needle pathway during 
the aspiration-ejection process. The collagen and BG densities (1.41 and 2.73 g/cm3, 
respectively) were implemented into the rule of mixtures to calculate the BG volume percent [19, 
20]. IDC and IDC-BG gels from a 75-25 initial collagen-BG ratio and produced through 8G and 
14G needle gauge numbers, the opposite ends of the current GAE processing spectrum, were 
selected for further analysis.  
In vitro and in vivo mineralization  
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Kokubo’s protocol for SBF [21] was used to investigate the mineralization potential of 
IDC and IDC-BG gel scaffolds, in vitro. The scaffolds were conditioned in 50 mL of SBF (i.e., a 
ratio of 1:7 mg/mL) at 37 °C and collected after 6 h, and at days 1, 3, 7, and 14. The samples 
were washed twice using deionized water immediately prior to chemical and structural 
characterizations. SBF solution was freshly prepared and exchanged at 48-h intervals. Two 
repeats were performed for each scaffold type and time point. 
In vivo mineralization and bioactivity tests of IDC and IDC-BG gel scaffolds were 
performed at the animal facility of McGill University. Surgical procedures were performed 
according to an experimental research protocol (#2013-7384; approved by the McGill University 
Animal Care Committee).  In turn, eighteen adult male Fischer-344 rats (250-300 g, Harlan) 
were transferred to an induction chamber and anesthetized using isoflurane inhalation (2-4% 
isofluorane gas vaporized in O2).  Animals were then transferred to a warm heating pad and 
ophthalmic ointment was applied to each eye to protect the conjunctival membrane in the 
absence of a blink reflex.  Anesthesia was maintained using 0.5-2% isoflurane delivered through 
a silicone nose cone and waste gases were scavenged using a coaxial Bain circuit and an 
activated charcoal canister.  Once a surgical depth of anesthesia was confirmed, a 2 cm wide by 
4 cm long area of fur immediately caudal of each scapula was trimmed using a Wahl Pocket Pro 
clipper followed by the application of depilatory cream for approximately 1 min to remove 
residual fur. The skin was aseptically prepared by alternate swabbing of chlorhexidine and 70% 
ethanol using saturated surgical gauze and ethanol wipes, respectively.  With a disposable #15 
scalpel blade, a small 0.5−1.0 cm incision was created along each flank.  Lidocaine was topically 
administered along the border of each incision to minimize pain.  The fascia between the skin 
and underlying muscle was then blunt dissected to create a subcutaneous space approximately 2 
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cm rostral and 2 cm caudal to the incision to accommodate needles used to inject IDC and IDC-
BG gel scaffolds (Fig. 1D). 
Two identical gel scaffolds (8G or 14G needle gauge numbers) were injected into each 
flank for a total of four scaffolds per animal (Table 2; number of rats: N = 3 for IDC and N = 6 
for IDC-BG groups).  The scaffolds containing either vehicle (i.e., DMEM) or BG were prepared 
under sterile conditions by aspiration through the bore of either an 8G or 14G needle. Skin 
incisions were immediately closed using 3−0 Ethilon nylon suture, and Carprofen was 
administered subcutaneously using a weight related dose (5-10 mg/kg) to control post-operative 
pain. The animal was revived by oxygen inhalation, returned to its cage and monitored for full 
ambulatory recovery. At either day 7 or 21 post-surgery, animals were euthanized by 
asphyxiation using CO2 inhalation followed by pneumothorax. The scaffolds were carefully 
harvested from the injection site in a necropsy suite for either X-ray micro-tomography followed 
by histological evaluation (formalin fixation), or chemical analysis (snap frozen in liquid 
nitrogen). 
Morphological characterization 
Nonlinear laser scanning microscopy was performed to investigate the ultra-structure of the 
IDC and IDC-BG gels. This technique allows in-depth imaging of the gel scaffolds, thus 
eliminating the artefacts associated with edge effects [22]. The scaffolds were fixed in 4% 
formaldehyde solution and embedded in optimal cutting temperature compound (Sakura Finetek, 
USA) before sectioning with a cryostat microtome into 50 μm slices within the bulk of the gel 
scaffolds and placed between two coverslips. The slides were placed on a Leica multiphoton 
confocal fluorescence imaging system (SP8; Leica, Germany), equipped with a 63x Leica 
glycerin-immersion objective. The laser excitation wavelength was set at 830 nm, and the 
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scattered signals were collected in the forward direction using one transmitted light 
photomultiplier tube (low-pass filter; 410 nm). The second harmonic generation (SHG) emission 
of the collagen under excitation was captured.  
The Leica system, equipped with synchronized dual-mode imaging of thick samples in 
both SHG and an infrared scanning gradient contrast modality (Dodt channel) allowed for 
investigating the different underlying structures in the sectioned IDC-BG gels by phase contrast, 
and provided an indication of the spatial distribution of the BG particles [23]. A similar concept 
was also used to track the progress of mineralization and cell infiltration within the IDC and 
IDC-BG scaffolds. 
Scanning electron microscopy (SEM) was used to characterize the progression of IDC-BG 
scaffolds mineralization as a function of time in SBF. Samples were prepared by fixation in a 
solution of 4% formaldehyde at 4 °C. Samples were rinsed three times with distilled water, and a 
serial dehydration process was carried out by sample immersion in 30, 50, and 70% ethanol 
solutions for 10 min periods followed by 80 and 90% ethanol for 15 min each, and 100% ethanol 
for 30 min prior to transfer to hexamethyldisilazane (Sigma Aldrich, Canada) for drying in 
chemical fume hood. Following gold coating, the samples were observed by SEM (FEI Inspect 
F50, FEI, USA) at an acceleration voltage of 5-10 kV. For elemental analysis, energy dispersive 
spectroscopy (EDS) using an attached EDAX and a TEAM EDS Analysis System was 
performed at 5kV on 3 unique surfaces areas. 
Chemical characterization  
Attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy was 
performed to investigate the structural properties of the scaffolds.  The samples were freeze-dried 
at -105 °C and 100 mtorr for 24 h, and then flattened using a pneumatic (10 bar) compressor to 
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enable direct contact between the sample and IR prism, and to preserve consistency among 
different samples with distinct CFDs. ATR-FTIR spectra were collected through a Spectrum 400 
(Perkin-Elmer, USA) using a resolution of 2 cm-1, an infrared range of 4000-650 cm-1 and 64 
scans.  The data were normalized to the absorbance of amide I in collagen (at 1643 cm-1). 
X-ray diffraction (XRD) patterns of the scaffolds were analyzed using a Bruker D8 
Advanced XRD (Bruker AXS Inc., USA) from 3 to 90° 2θ at 40 kV, 20 mA. Three 30°- frames 
were recorded for a 15 min period and then merged using EVA software (Bruker). The phase 
composition was characterized through a comparison of acquired diffractographs and peaks 
identified in the International Centre for Diffraction Data (ICDD) database. 
Micro-computed tomography 
Micro-computed tomography (micro-CT) analysis was used to investigate the extent of 
mineralization of IDC and IDC-BG gels at days 7 and 21 post subcutaneous injection. Samples 
were scanned with a SkyScan 1172 (Aartselaar, Belgium) scanner with tube settings of 50 kV 
and 200 µA, 5.0 µm pixel resolution, four-frame averaging, rotation step of 0.50 degrees, and no 
filter. The scan times were approximately 1 h per sample. Following scanning, a transverse 
reconstruction was performed using a beam hardening correction of 80-100%, a ring artifact 
correction of 15 and a proper misalignment correction (NRecon software, SkyScan), to generate 
2356 × 2356 pixel cross-sectional images. As-made IDC and IDC-BG gel scaffolds were 
scanned to provide a baseline for the beam attenuation (AT) calibration. Two-dimensional 
analysis (software CTAn, SkyScan) was carried out on a threshold of 0.064 AT to differentiate 
between non-mineralized (<0.064 AT) and mineralized (>0.064 AT) collagen for subcutaneous 
injections, which quantified mineralization and allowed for the three-dimensional reconstruction 
and visualization of the different phases (CTVol software, SkyScan). For each of the datasets, 
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the volume percent of mineralized region and fractal dimension were calculated using CTAn 
software. Three-dimensional images were also reconstructed for all samples. 
Histomorphometry 
Subcutaneously injected IDC and IDC-BG gel scaffolds were fixed in 10% buffered 
formaldehyde for 24 h, followed by three washes with distilled water before transferring into 
70% ethyl alcohol. Each specimen was processed following routine plastic embedding 
techniques (McGill Bone Centre). The process included chorological submersion of each 
specimen in 70, 80, 95 and 100% ethanol solutions for 12 h periods, followed by Xylene (Fisher) 
submersion for 3 h, and then embedding in methyl methacrylate, butyl methacrylate (Fisher 
Scientific), and methyl benzoate (Sigma Aldrich) for 12 h periods, respectively. The plastic 
blocks were serially sectioned with a microtome (Leica RM2165, Nussloch, Germany) into 6 µm 
slices along the transverse interface. The presence of mineralized regions was demonstrated by 
Toluidine blue-von Kossa staining. Adjacent slices were stained with Goldner’s Trichrome, to 
show the collagen fibrils and osteoid presence, and haematoxylin and eosin (H&E) to provide 
baseline comparisons. Further sections of those samples which, upon analysis, contained cells 
with osteoblast and osteoclast-like morphology were stained for alkaline phosphatase (ALP kit, 
86c, Sigma Aldrich) and tartrate resistant acid phosphatase (TRAP, 387A, Sigma Aldrich) to 
further characterise these cells. Sections were briefly deplasticised in acetone for 5 mins then 
rehydrated through decreasing alcohols to distilled water. They were incubated in staining 
solution of naphthol AS-BI Alkaline (ALP) or napthol AS-BI phosphoric acid (TRAP) according 
to the manufacturer’s instructions, rinsed with dH2O for 3 min and mounted in an aqueous 
mountant for viewing. 
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Images were acquired using a fluorescence microscope (BX51; Olympus Optical Co., 
Germany) in the bright-field mode and a colour video camera (Soft Imaging System, Germany). 
Images were taken at 4× magnification using ImagePro software (Media Cybernetics, USA) and 
merged to give a composite of the whole slice.  
Images were analyzed using the open-source software ImageJ (NIH, USA). The entire 
scaffold section was reconstructed using a plug-in mosaic, which is consistent with colour 
images. The amount of mineralization was calculated in the Toluidine blue-von Kossa slices as 
the area of black stained tissue within the confines of the implant, i.e., a percentage of the region 
of interest. The images were converted to 8-bit format, and a threshold was adjusted to measure 
only the black-stained areas of the composite image in terms of percentage. Thresholding was 
performed by maximum entropy algorithm, and then subjected to the black-white window. The 
region of interest around the IDC scaffold was selected manually, and the area fraction was 
calculated in the binary image mode.  
Statistical analysis 
Statistical analysis was performed in EXCEL 2010 (Microsoft, USA) using a two-way 
ANOVA where the main factors are the scaffold type, time point, and gauge number. The level 
for significance was set at p = 0.05. 
Results and Discussion 
Structural characterization of as-made IDC-BG hybrid gels 
The GAE system (Fig. 1A-C) enabled (in approximately 50 min) the scalable fabrication of 
rod-shaped IDC-BG hybrid gels with defined CFDs, which ranged from approximately 6 to 14 
wt% (Table 1). Along with an increase in CFD with higher gauge numbers, there was a reduction 
in BG microparticle loading, e.g., from 24 to 20 wt% in 8G through 14G (for an initial 25 wt% 
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loading). In terms of microstructural properties, schematic Gaussian distribution functions 
generated from SHG images represented the extent of the overall collagen fibrillar alignment 
along the longitudinal axis of IDC and IDC-BG scaffolds, which is indicated by the horizontal 
axis in the left columns of Fig. 2 A-B.  SHG images, corroborated by representative SEM 
micrographs (insets in middle column of Fig. 2), confirmed a decrease in the dispersion of fibril 
orientation (i.e., the standard deviation of the corresponding Gaussian function) with decreasing 
needle diameter from 8G (3.4 mm) to 14G (1.6 mm), which represented the opposite ends of the 
current GAE processing spectrum, and chosen in this study for analysis. Dodt images also 
confirmed the uniform spatial distribution of BG microparticles deep within IDC-BG scaffolds 
(Fig. 2C; right column). 
The GAE system applies a number forces onto the prefabricated HHC gels during 
compaction. This is initiated by a steep pressure differential that is applied via the pressure 
device (e.g., angioplasty inflation device in Fig. 1B) to generate negative pressure, which in turn 
uses atmospheric pressure as the driving force for compaction. Therefore, the fibrils in HHC 
gels, which interact through physical entanglements and secondary bonds (i.e., weak, non-
chemically cross-linked interactions) experience a two-dimensional compaction process along 
the circumference of the needle as the gel is aspirated into the orifice of a densification needle. 
This is thought to provide the driving force behind fibrillar rearrangement and the alignment is 
induced since the shearing forces exceed the frictional forces established between the randomly 
arranged fibrils, which are then repositioned along the direction of shear flow. 
Mineralization in SBF 
The progress of in vitro mineralization within IDC and IDC-BG gel scaffolds was 
investigated for up to day 14 in SBF. Fig. 3A illustrates representative SEM micrographs of 
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IDC-BG gel scaffolds as-made, and at days 3 and 14 in SBF (Fig. S1 provides more extensive 
time points) at two length scales. Scaffold immersion in SBF led to the development of apatite 
crystal-like structure formation on the surface of collagen fibrils, with typical cauliflower 
morphologies that increased in size and became appeared more granular in shape at longer 
immersion times [24]. 
ATR-FTIR spectroscopy and XRD analyses were used to characterize the formed mineral. 
ATR-FTIR spectra of as-made IDC scaffolds displayed the typical amide absorption bands of 
collagen fibrils at 1643, 1550 and 1243 cm-1 for Amide I, II and III, respectively (Fig. 3B; left 
column) [9]. The spectrum of BG exhibited the presence of Si-O-Si vibration mode within the 
1000–1100 cm-1 region, and the non-bridging oxygen bond (Si-O-NBO) at around 900 cm-1 (Fig. 
S2A) [25]. The presence of network modifiers provokes disruption of the glassy network through 
breaking of the Si-O-Si bonds, thus leading to formation of Si-O-NBO groups. The addition of 
BG microparticles to IDC yielded a dominant effect of silicate and phosphate vibrations, which 
masked the side chain vibrations within a wavelength range of 1100-800 cm-1 (Fig. 3B). Since 
the absorbance of Si-O-Si and PO43- groups overlap, the peak at approximately 1000 cm-1 can be 
attributed to both silicate and phosphate bonds [16]. The peak at 900 cm-1 also shifted to 920 cm-
1 in the IDC-BG system, which can be due to a lower amount of Si-O-NBO as well as the 
formation of Si-OH bonds from BG/water interactions. The weak peak at around 870 cm-1 is also 
attributed to a double absorbance of CO32- and HPO42- groups [9]. 
Post immersion in SBF, the FTIR spectra of IDC-BG scaffolds showed a slight shift in the 
wavenumber of amide I absorption along with an increase in the absorption bands of PO43- and 
CO32- at 1022 and 874 cm-1, respectively (Fig. 3B); attributable to the formation of crystalline 
CHA within the scaffolds [9]. In addition, there was a progressive increase in absorbance of the 
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Si-O-Si peaks, at 1100 and 803 cm-1 [26].  The XRD diffractographs of IDC-BG scaffolds 
indicated the progressive intensification of the characteristic peaks of hydroxyapatite with time 
in SBF, and by day 14, the broad diffraction peak at 2θ ~ 20o in the as-made gels (corresponding 
to collagen structural characteristics, along with the amorphous nature of BG; Fig S2) was 
replaced by peaks such as 2θ ~ 32o, indicative of formation of low crystalline apatite (Fig. 3C; 
right column). XRD analysis (in line with ATR-FTIR), indicated similar trends for CHA 
formation in IDC-BG gel scaffolds produced through 8G and 14G needles (Fig. S2). EDAX 
analysis confirmed the co-presence of Si, Ca and P in the mineralized IDC-BG scaffolds (Fig. 
S2). IDC scaffolds, on the other hand, only showed indications of CHA formation at day 7 in 
SBF, followed by the presence of detectable CHA at day 14 (Fig. 3B-C, left columns) [15].  
Typical tensile stress-strain curves generated for IDC and IDC-BG gel scaffolds (produced 
through 14G), as-made, and as a function of time in SBF, provided an indication of the effect of 
mineralization on gel scaffold mechanical properties (Fig. S3). As-made IDC and IDC-BG gels 
demonstrated typical toe, linear and failure regions associated with dense collagen gels [9, 16, 
17, 27]. The progressive increase in mineralization in IDC-BG gels triggered a transition from 
soft-to-hard tissue-like response to tensile force, as indicated by the stress-strain curve tending 
towards the y-axis (Fig. S3B); indicating an increase in the stiffness of the scaffolds. This was in 
contrast to minor changes in stress-strain curves of the IDC gel scaffolds over time in SBF (Fig. 
S3A) [9]. 
In vivo mineralization 
To extend upon the above findings and evaluate the feasibility of GAE in a surgical 
context, acellular gel scaffolds were subcutaneously injected into the flanks of adult rats.  At 
days 7 and 21 following subcutaneous injection, rats were euthanized and the scaffolds were 
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extracted.  In general, post-implanted IDC and IDC-BG scaffolds exhibited a planar morphology 
most likely due to material compression under the weight of the animal during normal waking 
activity.  Scaffolds were well retained within the subcutaneous injection site and did not appear 
to shift laterally or along the rostro-caudal axis.  IDC-BG scaffolds were noticeably more rigid 
than IDC scaffolds and at day 21 appeared qualitatively more resistant to deformation during 
sample isolation and handling than those collected at day 7.  In addition, at day 21, the IDC and 
IDC-BG scaffolds were often bonded to subcutaneous connective tissues with no gross signs of 
inflammation. In some cases, tissue attachment was present along the dorsal surface of the 
scaffold, where the attachment could not be manually dissociated during sample collection. 
Compared to as-made gels, and subcutaneously implanted IDC gels, three-dimensional 
reconstruction of micro-CT scans of IDC-BG gel scaffolds at days 7 and 21 post implantation 
illustrated an increase in the attenuation of x-ray; confirming the presence of an increasingly 
dense material, i.e., mineralization (Fig. 4A). Analysis of micro-CT data confirmed the 
significant (p < 0.05; where main factors are the implant type and dissection time) rapid increase 
in mineralized volume percent of collagen in IDC-BG scaffolds (Table 3). At day 21, IDC gel 
scaffolds exhibited a mineralized phase of 5-15%, indicating spontaneous deposition of calcium 
ions on the surface of collagen fibrils. In contrast, the mineralized phase in IDC-BG gel scaffolds 
was significantly higher, reaching 40-50%. There were no significant (p > 0.05) differences in 
the extent of mineralization between similar groups generated from the two different gauge 
numbers. Furthermore, there was a significant (p < 0.05; where main factors are the implant type 
and dissection time) decrease in fractal dimension in IDC-BG at day 21, suggesting an increase 
in the stiffness of the scaffolds [28].  
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ATR-FTIR and XRD analyses characterized the mineralization of subcutaneously injected 
IDC and IDC-BG gels (Fig. 4 B&C, respectively). ATR-FTIR spectra indicated the progressive 
mineralization of IDC-BG gels, as the absorbance peaks associated with phosphate and 
carbonate bonds emerged at days 7 and 21, comparable to those detected in vitro (Fig. S2). XRD 
diffractographs of explanted IDC-BG scaffolds showed the main hydroxyapatite peak around 2θ 
~ 32o at day 7, in addition to a broad hump of the collagen matrix. At day 21 post injection, 
additional peaks were exhibited that corresponded with hydroxyapatite, similar to those 
demonstrated in vitro. The evolution of XRD patterns confirmed the rapid rate of mineralization 
in IDC-BG scaffolds and was in contrast to those of IDC scaffolds, which lacked the diffraction 
peaks associated with hydroxyapatite.  
Standard Toluidine blue-von Kossa staining showed that both IDC and IDC-BG scaffolds 
contained mineralized regions (black staining; Fig. 5). However, the pattern of mineralization 
was different in each group, where it generally occurred in the centre of IDC scaffolds, not 
reaching the surrounding capsule, and in contrast to that in IDC-BG, where mineralisation was 
observed around the edges and up to the sub-capsular space (Fig. 6). Quantification of von Kossa 
staining indicated that the mineralized area percent in explanted IDC-BG was significantly 
greater (p < 0.05; where main factors were the implant type and dissection time) than in IDC 
scaffolds (Table 4), as indicated by micro-CT analysis (Table 3). On the other hand, the 
mineralized area percent was not sensitive to the gauge number (p = 0.13; where main factors 
were the gauge number and dissection time), which also correlated with the micro-CT analysis. 
Goldner’s Trichrome stained histological sections confirmed the presence of collagen-rich 
regions (green fibril staining in Fig. 5) in both IDC and IDC-BG scaffolds, along with directional 
orientation of collagen fibrils within the gel scaffolds. 
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Histological analysis of the IDC and IDC-BG gel scaffolds showed that all implants 
became encapsulated in the subcutaneous tissue. The capsule thickness varied both between and 
within samples although in general it was approximately 1-2 cells thick (Fig. 6). Cell infiltration 
was present in both groups, beginning at the edges of the injected scaffolds and penetrating 
between collagen fibrils and along any channels or folds in the scaffolds. Cell infiltration was 
more evident in the IDC-BG group and increased with time. At day 21, cell infiltration into IDC 
was similar to that seen in IDC-BG scaffolds at day 7 and was characterised by individual cells 
penetrating into the dense collagen network, with sections remaining un-colonized (Fig. 6).  By 
contrast, at day 21, cell infiltration in IDC-BG had progressed to islands of disorganized 
granulation tissue between denser areas of un-colonized scaffold that did not seem to be related 
to needle gauge size.  Furthermore, in the majority of samples in this group, this tissue showed 
significant signs of remodelling with cells resembling osteoblasts, osteoclast-like cells lining the 
scaffold/tissue interface, the presence of osteoid and areas of tissue which had the appearance of 
woven bone (Figs. 6 and S4). Upon further analysis, it was confirmed that cells in these areas 
expressed appropriate markers for osteoblasts (ALP) and osteoclasts (TRAP) (Fig. S4).   
This organization of tissue was accompanied by significant neovascularization, the early 
signs of which were visible at day 7 in IDC-BG (Figs. 6 and S4). There was no evidence of 
vascularization in the IDC group at day 7 although vessels were seen in this group at day 21. 
Furthermore, in some samples, the BG particles formed local agglomerates that were visible both 
at days 7 and 21. At the earlier time point, this invoked a foreign body giant cell response, but by 
day 21 the agglomerates seemed to be the site of osteoid formation, as confirmed by H&E and 
Goldner’s Trichrome staining (Fig. 6). No foreign body reaction was seen in the IDC groups. 
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Much of the histological findings in this study are supported by previous reports, where 
others have demonstrated similar capsule formation and/or cell infiltration into poly(3-
hydroxybutyrate)/BG composite foams [29], poly(ε-caprolactone/D,L-lactide)/BG scaffolds [30], 
nanoporous bioactive glass scaffolds [31] and bioactive glass particles [32] when implanted 
subcutaneously either in rats [29, 30, 32] or New Zealand white rabbits [31]. Similarly, the 
proangiogenic properties of bioactive glasses have been widely reported, where they have been 
shown to induce increased vascular endothelial growth factor (VEGF) and basic fibroblast 
growth factor expression by endothelial cells or fibroblasts [14, 33, 34] and enhanced tubule 
formation and branching of endothelial cell cultures [14, 33], in vitro. In vivo, the presence of 
BG in composites of poly(D,L-lactide-co-glycolide) [35] and polyglycolic acid [34] and glass-
coated collagen [8] was associated with increased vascularization as measured by blood vessel 
count or haemoglobin content.  Even the observation of BG agglomerations and giant cell 
formation has been reported elsewhere [29, 30].  There is evidence that BG has direct osteogenic 
and mineralogenic effects in vitro through the promotion of ALP activity and the enhanced 
expression of osteogenic genes such as osteocalcin, RUNX2, BMP2, BMP6, osterix, bone 
sialoprotein, osteonectin and collagen I [36-39], yet, while bone induction in an ectopic 
intramuscular site has been previously reported by BG generated glass-ceramic scaffolds [40], no 
previous study has reported BG-induced bone formation in a subcutaneous site without the 
addition of osteogenic cells (despite implantation times ranging from 7 to 60 days).  
In discussing osteoinductive calcium phosphates, Habibovic and de Groot [41] described 
the conditions required for osteoinduction to occur in the absence of strong evidence of 
sequestered bone morphogenetic protein involvement (the classical mechanism of 
osteoinduction). They suggest that the required material properties are the presence of macro- 
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and micro-pores post-implantation and the formation of a CHA layer which could act either as a 
trigger for osteogenic differentiation of local stem cells or could include growth factors that drive 
the process. Certainly, IDC-BG gels satisfy both of these criteria with folds, channels and pores 
allowing cell infiltration and von Kossa staining demonstrating early mineralization of the 
scaffold. Furthermore, given the proangiogenic and osteogenic properties of BG [36, 39, 42], it is 
probable that both material and biological characteristics of the IDC-BG scaffold are 
contributing to the phenomenon of osteoinduction: in addition to the direct stimulation of 
osteogenesis and mineralisation that may be stimulated by BG, angiogenesis and osteogenesis 
are closely related and the presence of VEGF has been shown to enhance bone healing in 
orthotopic sites [43]. Indeed, the sites of tissue remodelling and woven bone-like tissue reported 
here were always co-localised with multiple blood vessels. Habibovic and de Groot [41] also 
suggested that osteoinduction in rodent subcutaneous models is rare as this is a less inductive site 
than the intramuscular sites usually chosen in larger animals such as dog and goat.  Therefore, 
the results of the in vivo models described above, where good cell infiltration and vascularization 
of BG/composite scaffolds was reported, but no bone formation was seen, would support this 
suggestion and makes the results reported here more promising, particularly as evidence would 
suggest that increased osteoinductive properties of a scaffold will translate into increased bone 
formation in an orthotopic site [41]. 
SHG imaging of explanted scaffolds indicated remodelling within the mineralized regions 
(Fig. 7; Fig. S5 provides larger views), where small mineral nodules were percolated into the 
IDC-BG scaffolds over time. Collagen fibrils in the localized mineralization regions were 
observed to be highly aligned and bundle shaped, while gradually transitioning to more isotropic 
fibrils in non-mineralized regions with visible disruption in the orientation of collagen fibrils 
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across the transition regions. It has been previously shown that the culturing of pre-osteoblasts, 
three-dimensionally seeded in BG incorporated dense collagen gels of random fibrillar 
orientation, resulted in their preferential orientation and adjacent to highly aligned, mineralized 
collagen fibrils [9]. More recently, it was demonstrated that the osteoblastic differentiation of 
mesenchymal stem cells and matrix mineralization was accelerated when seeded in aligned IDC 
gels compared to similar gels of random fibrillar orientation [18]. The sparse distributions of the 
SHG signal intensity (i.e., a mixture of very bright and dark regions in Fig. 7C) also confirmed 
their planar shape as the incident laser beams were linearly polarized. This was in contrast to the 
more coherent intensity distribution in the non-mineralized regions, or in as-made gels (Fig. 2). 
The Dodt images provide further evidence for cellular infiltration and mineralization within the 
IDC-BG scaffolds (Figs. 7 and S5), suggesting that this deep tissue imaging technique may 
provide a quantitative tool to assess the progression of mineralization [23]. 
In contrast to the as-made scaffolds, where collagen fibrils aligned along the longitudinal 
direction (Fig. 2), collagen fibrils of explanted scaffolds showed less directionality (Fig. 7), 
demonstrating parallel alignment in the edges and more isotropically distributed in central 
regions (Fig. S5). SHG imaging also indicated that the distribution in collagen orientation of 
explanted 8G and 14G IDC scaffolds were similar. Attributable to the symmetry in physiological 
conditions between the two flank sites, the collagen microstructure remodelled towards a similar 
configuration in both scaffolds. This would justify the low statistical difference in 
histomorphometry and micro-CT measurements between the two gauge numbers and may be due 
to the non-confined positioning of the scaffold when subcutaneously implanted, evolving toward 
a flattened disk shape and altering the initial CFD value. It is anticipated that the physiological 
conditions will be different in an orthotropic site. 
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Potential outlook for in situ bone defect injection  
Since a substantial fraction of bone defects do not heal properly using bone autografts, the 
gold standard treatment, alternative strategies have relied on the osteoconductive or 
osteoinductive capabilities of an implanted tissue such as an allograft or synthetic materials such 
as bioceramics [44]. On the other hand, bone tissue engineering is diversifying toward 
biologically derived biodegradable materials and their integration with therapeutic cells and 
bioactive factors. With the current limitations of orthobiologic products [7], there is a need for 
the development of new biomaterial scaffolds. The utilization of a GAE system in this study, 
rapidly and simply generated cylindrical-shaped IDC-BG hybrid gels with controllable CFD 
values and microstructural properties, thus potentially enabling the minimally invasive delivery 
of more stable dense collagen gel scaffolds into a surgical site, something which has previously 
been challenging [45]. To reduce large tissue voids and gaps for bone repair, IDC gel fabrication 
can be readily scaled, with little increase in processing time, for example, by using larger 
cylindrical moulds to accommodate larger volumes of precursor HHC gels. As such, the GAE 
injectable hydrogel system could potentially address a number of current issues including cost 
and risks associated with multiple treatments. Moreover, the addition of BG to the gel seemed to 
infer osteoinductive properties that have not previously been reported. Most synthetic bone 
substitutes are osteoconductive only and the addition of an osteoinductive capability would 
suggest the possibility of enhanced clinical performance with this scaffold. Therefore, future 
studies will be required to investigate the injection of IDC-BG scaffolds into bone defects.  
Conclusions 
A GAE system was used to rapidly fabricate IDC-BG gel scaffold that demonstrated 
bioactive and osteoinductive properties, as indicated by the formation of CHA in SBF and bone-
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like material in an ectopic environment, in vivo. SHG imaging demonstrated collagen 
remodelling associated with mineralization in subcutaneously injected IDC-BG scaffolds. The 
proposed IDC-BG hybrid gel potentially offers an efficient approach for therapeutics requiring 
an injectable delivery of a bone graft and may provide enhanced clinical performance over 
currently available alternatives. 
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Figure Captions: 
Figure 1. IDC and IDC-BG gel scaffold production and subcutaneous injection through 
GAE. (A) Schematic representation of the IDC-BG gel scaffold fabrication.  Time marks 
illustrate rapidity of the process (total time is less than 50 min). (B) Schematic of GAE system 
showing its precursor highly-hydrated gel in a 48 well plate before and during processing. (C) In 
vivo study showing fabrication of the precursor and aspiration process in a 14G needle in the 
procedure room; and (D) placement of one hybrid gel implant in the left flank of the rat. 
Figure 2. Collagen fibrillar orientation. (A) SHG images (left and middle columns) and Dodt 
image (right column) of an IDC gel scaffold fabricated by 8G needle, (B) an IDC gel scaffold 
fabricated by 14G needle, and (C) an IDC-BG gel scaffold fabricated by 14G needle. SHG and 
Dodt images were generated for the same chosen region. The Gaussian distributions in (B) & (C) 
indicated the of overall fibrillar orientation in the IDC-based gels produced through the two 
gauge numbers.  Insets in middle column showing representative SEM micrographs. White 
arrows in (C) indicate BG microparticles within the IDC-BG gel scaffold.  
Figure 3.  Mineralization in SBF. (A) SEM micrographs of IDC-BG gel scaffolds fabricated by 
14G needle as-made, and at days 3 and 14 in SBF. (B) ATR-FTIR spectra of IDC (left column) 
and IDC-BG (right column) gel scaffolds fabricated by 14G needle as a function of time in SBF. 
(C) XRD diffractographs of IDC (left column) and IDC-BG (right column) gel scaffolds 
fabricated by 14G needle as a function of time in SBF. The standard peaks for hydroxyapatite, 
based on the International Centre for Diffraction Data, are shown in the right column.  
Figure 4.  In vivo mineralization. (A) Micro-CT (based on the attenuation values) images of 
representative IDC and IDC-BG gel scaffolds as-made and at days 7 and 21 post subcutaneous 
injections. (B) ATR-FTIR spectra of explanted gel scaffolds in right flank and (C) both flanks at 
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day 21. (D) XRD patterns of explanted gel scaffolds in right flank with standard hydroxyapatite, 
and (E) both flanks at day 21. 
Figure 5.  Gross histological analysis of subcutaneously injected scaffolds. Histology images 
of representative IDC and IDC-BG gel scaffolds as-made and at days 7 and 21 post subcutaneous 
injection. High-power insets in as-made IDC and IDC-BG gels indicate the distribution of 
collagen fibrils (Goldner’s Trichrome) and BG microparticles (von Kossa-Toluidine blue: yellow 
arrows). 
Figure 6. Histological analysis of implants. Top row: Capsule formation was evident around 
the scaffolds at day 7. In most instances the capsule was 1-2 cells thick (arrows). Mineralized 
tissue (black stained) did not quite reach the capsular membrane in the IDC group, but reached 
the sub-capsular layers in the IDC-BG group. Second row: Cell infiltration into the scaffolds was 
indicated (arrows), which was less pronounced in the IDC groups at both days 7 and 21. Cells 
had penetrated into the centre of IDC-BG at day 7 and by day 21 islands of cells had developed 
within the scaffold (white arrow) and there was separation of the collagen fibrils (red arrow). 
Third row: Neovascularization was evident within the confines of the scaffold. No blood vessels 
were seen in the IDC group at day 7, but some small vessels were visible at the edges of the 
IDC-BG scaffolds (arrows). By day 21, there was significant neovascularization in both IDC and 
IDC-BG scaffolds in the areas of tissue/cell penetration. Fourth row: The BG particles formed 
local agglomerations (black arrows) in some instances, which stimulated a foreign body giant 
cell response (white arrows) at day 7 but at day 21 seemed to be the site of osteoid formation 
(red arrows). Fifth row: Further evidence of scaffold remodelling and osteoinduction in the IDC-
BG group at day 21 was observed with the presence of cells phenotypically similar to both 
osteoblasts (column 1, confirmed by ALP staining shown in Fig. S4) and osteoclasts (confirmed 
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by TRAP staining shown in Fig. S4), at the scaffold/tissue interface (column 2), and remodelling 
of the collagenous material (column 3) into tissue with the appearance of woven bone (column 
4). Key: S = scaffold, H&E = haematoxylin and eosin, TB&vK = Toluidine blue and von Kossa, 
G Tri = Goldner’s Trichrome.  
Figure 7. Imaging of collagen fibrils in explants. (A) SHG and Dodt images of subcutaneously 
injected IDC gel at day 7, (B) IDC-BG at day 7, and (C) IDC-BG at day 21. White arrows in (A) 
and (B) indicate the infiltration of particles and cells, respectively. 
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Table 1. The equivalent collagen fibrillar density (CFD; obtained from IDC scaffolds and 
assuming that no collagen was lost during gelation and the GAE fabrication process) and BG 
mass and volume percent in IDC-BG gel scaffolds for two distinct collagen-BG mass ratios (N = 
3). 
 
Initial collagen-BG 
mass ratio (dry wt %) 
Gauge number 8G 10G 12G 14G 
Diameter (mm) 3.43 2.69 2.16 1.60 
100-0 CFD (wt %) 5.74 ± 0.14 8.30 ± 0.75 11.04 ± 0.94 13.82 ± 2.06 
75-25 
 
Solid mass 
content (wt %) 
7.12 ± 0.17 
 
10.15 ± 0.92 
 
13.34 ± 1.14 
 
16.59 ± 2.47 
 
 Practical BG mass (wt %) 
24.06 ± 0.77 
 
22.24 ± 0.47 
 
20.87 ± 0.83 
 
20.03 ± 0.85 
 
 Practical BG volume (vol %) 
0.49 
 
0.74 
 
0.85 
 
1.46 
 
50-50 
 
Solid mass 
content (wt %) 
8.59 ± 0.21 
 
12.23 ± 1.10 
 
16.02 ± 1.36 
 
19.99 ± 2.98 
 
 Practical BG mass (wt %) 49.66 ± 0.71 47.31 ± 0.42 45.13 ± 0.80 44.72 ± 0.82 
 Practical BG volume (vol %) 
1.63 
 
2.72 
 
3.67 
 
4.65 
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Table 2. The number of animals assigned for each treatment as well as the characterization 
types. 
 
Animal 
number 
Implant 
type 
Gauge 
number 
Dissection 
time (day) 
Characterization type 
micro-CT/histology chemical analysis 
1-3 
 
IDC 8G  
7 
 
 
3 3 
 14G 3 3 
4-6 
 
 8G  
21 
 
 
3 3 
 14G 3 3 
7-12 
 
IDC-BG 8G  
7 
 
 
6 6 
 14G 6 6 
13-18 
 
 8G  
21 
 
 
6 6 
 14G 6 6 
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Table 3. Quantification of micro-CT analysis. The presence of BG particles in the 
subcutaneously injected hybrid gel scaffolds increased both the mineralized volume percent and 
fractal dimension (p < 0.05; by a two-way ANOVA where the factors are implant type and 
dissection time). 
 
Implant Dissection time (day) Gauge number Mineralized volume percent (%) Fractal dimension 
IDC as-made 8G 0 2.96 ± 0.02 
  14G 0 2.95 ± 0.01 
IDC-BG as-made 8G 0 2.96 ± 0.02 
  14G 0 2.94 ± 0.01 
IDC 7 8G 1.15 ± 1.04 2.95 ± 0.01 
  14G 1.81 ± 0.81 2.97 ± 0.02 
 21 8G 11.49 ± 7.61 2.92 ± 0.04 
  14G 10.31 ± 5.04 2.89 ± 0.03 
IDC-BG 7 8G 9.73 ± 1.91 2.93 ± 0.03 
  14G 11.30 ± 3.29 2.92 ± 0.03 
 21 8G 40.33 ± 7.70 2.80 ± 0.05 
  14G 44.37 ± 6.03 2.69 ± 0.06 
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Table 4. Quantification of von Kossa staining of histological sections. The presence of BG 
particles in the subcutaneously injected hybrid gels significantly (p < 0.05; by a two-way 
ANOVA where the factors are implant type and dissection time) increased the mineralized area 
percent. 
 
Implant Dissection time (day) Gauge number Mineralized area percent (%) 
IDC 7 8G 2.92 ± 2.81 
  14G 2.86 ± 2.14 
 21 8G 13.14 ± 10.90 
  14G 8.58 ± 7.53 
IDC-BG 7 8G 15.91 ± 2.65 
  14G 16.12 ± 2.32 
 21 8G 53.53 ± 9.61 
  14G 47.23 ± 5.13 
 
